Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-02
2011-08-02
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S349000, C540S527000, C546S297000
Reexamination Certificate
active
07989441
ABSTRACT:
The present disclosure relates to XIAP inhibitor compounds of the formula I.
REFERENCES:
patent: 5521179 (1996-05-01), Bernstein et al.
patent: 2004/0242494 (2004-12-01), Brenchley et al.
patent: WO 03/065987 (2003-08-01), None
patent: WO 2004/072641 (2004-08-01), None
patent: WO 2005/069894 (2005-08-01), None
patent: WO 2006/010118 (2006-01-01), None
patent: WO 2006/017295 (2006-02-01), None
Database Registry, Mar. 13, 2006, XP002402671, compounds 876623-04-0, 876623-02-8.
Sushil K. Sharma, “Development of Peptidomimetics Targeting IAPs”, International Journal of Peptide Research and Therapeutics, 12(1)2006(21-32).
Uma Screenivasan, “Synthesis and Dopamine Receptor Modulating Activity of Lactam Conformationally Constrained Analogues of Pro-Leu-Gly-NH2”, Journal of Medicinal Chemistry, 1993, 36, 256-263.
Chen Zhuoliang
Palermo Mark G.
Sharma Sushil K.
Smith Troy
Straub Christopher S.
Davis Zinna Northington
Novartis AG
LandOfFree
Organic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2641815